Works by Vellenga, Edo


Results: 99
    1
    2
    3
    4

    Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 5, p. 1146, doi. 10.1080/10428194.2018.1522438
    By:
    • Labrador, Jorge;
    • Luño, Elisa;
    • Vellenga, Edo;
    • Brunet, Salut;
    • González-Campos, José;
    • Chillón, Maria C.;
    • Holowiecka, Aleksandra;
    • Esteve, Jordi;
    • Bergua, Juan;
    • González-Sanmiguel, José D;
    • Gil, Cristina;
    • Tormo, Mar;
    • Salamero, Olga;
    • Manso, Felix;
    • Fernández, Isolda;
    • de laSerna, Javier;
    • Moreno, María-José;
    • Pérez-Encinas, Manuel;
    • Krsnik, Isabel;
    • Ribera, Josep-Maria
    Publication type:
    Article
    5

    An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 4, p. 1030, doi. 10.1080/10428194.2018.1516875
    By:
    • Sobas, Marta;
    • Montesinos, Pau;
    • Boluda, Blanca;
    • Bernal, Teresa;
    • Vellenga, Edo;
    • Nomdedeu, Josep;
    • González-Campos, Jose;
    • Chillón, Maria;
    • Holowiecka, Aleksandra;
    • Esteve, Jordi;
    • Bergua, Juan;
    • González-Sanmiguel, José David;
    • Gil-Cortes, Cristina;
    • Tormo, Mar;
    • Salamero, Olga;
    • Manso, Felix;
    • Fernández, Isolda;
    • de la Serna, Javier;
    • Moreno, María-José;
    • Pérez-Encinas, Manuel
    Publication type:
    Article
    6
    7
    8

    Daratumumab in transfusion‐dependent patients with low or intermediate‐1 risk myelodysplastic syndromes.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 4, p. E111, doi. 10.1002/ajh.26095
    By:
    • Garcia‐Manero, Guillermo;
    • Diez‐Campelo, Maria;
    • Vellenga, Edo;
    • Jacoby, Meagan A.;
    • Merchan, Brayan;
    • Breems, Dimitri;
    • Cortelezzi, Agostino;
    • Doronin, Vadim;
    • Gomez, Valle;
    • Beckers, Marielle;
    • Della Porta, Matteo Giovanni;
    • Varsos, Helen;
    • Xiu, Liang;
    • DeAngelis, Nikki;
    • Nnane, Ivo;
    • Rose, Esther;
    • Eygen, Koen
    Publication type:
    Article
    9

    Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 7, p. 732, doi. 10.1002/ajh.23728
    By:
    • Gambacorti-Passerini, Carlo;
    • Brümmendorf, Tim H.;
    • Kim, Dong-Wook;
    • Turkina, Anna G.;
    • Masszi, Tamas;
    • Assouline, Sarit;
    • Durrant, Simon;
    • Kantarjian, Hagop M.;
    • Khoury, H. Jean;
    • Zaritskey, Andrey;
    • Shen, Zhi-Xiang;
    • Jin, Jie;
    • Vellenga, Edo;
    • Pasquini, Ricardo;
    • Mathews, Vikram;
    • Cervantes, Francisco;
    • Besson, Nadine;
    • Turnbull, Kathleen;
    • Leip, Eric;
    • Kelly, Virginia
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    Comparative Value of Post-Remission Treatment in Cytogenetically Normal AML Subclassified by NPM1 and FLT3-ITD Allelic Ratio.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S27, doi. 10.1016/j.clml.2016.07.039
    By:
    • Versluis, Jurjen;
    • Hout, Florentien in 't;
    • Devillier, Raynier;
    • van Putten, Wim;
    • Manz, Markus;
    • Vekemans, Marie-Christiane;
    • Legdeur, Marie-Cecile;
    • Passweg, Jakob;
    • Maertens, Johan;
    • Kuball, Jurgen;
    • Biemond, Bart;
    • Valk, Peter;
    • van der Reijden, Bert;
    • Meloni, Giovanna;
    • Schouten, Harry;
    • Vellenga, Edo;
    • Pabst, Thomas;
    • Willemze, Roel;
    • Lowenberg, Bob;
    • Ossenkoppele, Gert
    Publication type:
    Article
    16

    Analysis of Efficacy and Prognostic Factors of Lenalidomide Treatment as Part of a Dutch Compassionate Use Program.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 2, p. 138, doi. 10.3816/CLML.2010.n.020
    By:
    • Kneppers, Evelien;
    • Lokhorst, Henk M.;
    • Eeltink, Corien M.;
    • Huls, Gerwin;
    • Kersten, Marie José;
    • Koedam, Jan;
    • Minnema, Monique C.;
    • van Oers, Marinus H. J.;
    • Raymakers, Reinier A. P.;
    • Schaafsma, Martijn R.;
    • Vellenga, Edo;
    • Wijermans, Pierre W.;
    • Wittebol, Shulamiet;
    • Sonneveld, Pieter;
    • Zweegman, Sonja
    Publication type:
    Article
    17
    18
    19
    20
    21

    All- trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.

    Published in:
    Annals of Hematology, 2015, v. 94, n. 8, p. 1347, doi. 10.1007/s00277-015-2393-0
    By:
    • Sanz, Miguel;
    • Montesinos, Pau;
    • Kim, Haesook;
    • Ruiz-Argüelles, Guillermo;
    • Undurraga, María;
    • Uriarte, María;
    • Martínez, Lem;
    • Jacomo, Rafael;
    • Gutiérrez-Aguirre, Homero;
    • Melo, Raul;
    • Bittencourt, Rosane;
    • Pasquini, Ricardo;
    • Pagnano, Katia;
    • Fagundes, Evandro;
    • Vellenga, Edo;
    • Holowiecka, Alexandra;
    • González-Huerta, Ana;
    • Fernández, Pascual;
    • Serna, Javier;
    • Brunet, Salut
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28

    Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols.

    Published in:
    European Journal of Haematology, 2020, v. 104, n. 3, p. 162, doi. 10.1111/ejh.13346
    By:
    • Sobas, Marta;
    • Rodriguez‐Veiga, Rebeca;
    • Vellenga, Edo;
    • Paluszewska, Monika;
    • De la Serna, Javier;
    • García‐Álvarez, Flor;
    • Gil, Cristina;
    • Brunet, Salut;
    • Bergua, Juan;
    • González‐Campos, Jose;
    • Ribera, José María;
    • Tormo, Mar;
    • González, Marcos;
    • Fernández, Isolda;
    • Benavente, Celina;
    • González‐Sanmiguel, Jose D.;
    • Esteve, Jordi;
    • Pérez‐Encinas, Manuel;
    • Salamero, Olga;
    • Manso, Felix
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Bone marrow dysfunction in chronic heart failure patients.

    Published in:
    European Journal of Heart Failure, 2010, v. 12, n. 7, p. 676, doi. 10.1093/eurjhf/hfq061
    By:
    • Westenbrink, B. Daan;
    • Voors, Adriaan A.;
    • de Boer, Rudolf A.;
    • Schuringa, Jan J.;
    • Klinkenberg, Theo;
    • van der Harst, Pim;
    • Vellenga, Edo;
    • van Veldhuisen, Dirk J.;
    • van Gilst, Wiek H.
    Publication type:
    Article
    47

    Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial.

    Published in:
    Genes, Chromosomes & Cancer, 2017, v. 56, n. 7, p. 524, doi. 10.1002/gcc.22455
    By:
    • Stevens‐Kroef, Marian J.;
    • Olde Weghuis, Daniel;
    • ElIdrissi‐Zaynoun, Najat;
    • van der Reijden, Bert;
    • Cremers, Eline M. P.;
    • Alhan, Canan;
    • Westers, Theresia M.;
    • Visser‐Wisselaar, Heleen A.;
    • Chitu, Dana A.;
    • Cunha, Sonia M.;
    • Vellenga, Edo;
    • Klein, Saskia K.;
    • Wijermans, Pierre;
    • de Greef, Georgine E.;
    • Schaafsma, M. Ron;
    • Muus, Petra;
    • Ossenkoppele, Gert J.;
    • van de Loosdrecht, Arjan A.;
    • Jansen, Joop H.
    Publication type:
    Article
    48
    49
    50